Bolzon Bradley J Phd - Net Worth and Insider Trading
Bolzon Bradley J Phd Net Worth
The estimated net worth of Bolzon Bradley J Phd is at least $66 Million dollars as of 2024-05-14. Bolzon Bradley J Phd is the Director, 10% Owner of Black Diamond Therapeutics Inc and owns about 6,471,188 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $38 Million. Bolzon Bradley J Phd is also the Director of CRISPR Therapeutics AG and owns about 498,558 shares of CRISPR Therapeutics AG (CRSP) stock worth over $28 Million. Details can be seen in Bolzon Bradley J Phd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bolzon Bradley J Phd has not made any transactions after 2021-07-19 and currently still holds the listed stock(s).
Transaction Summary of Bolzon Bradley J Phd
Bolzon Bradley J Phd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bolzon Bradley J Phd owns 10 companies in total, including Black Diamond Therapeutics Inc (BDTX) , CRISPR Therapeutics AG (CRSP) , and Flexion Therapeutics Inc (FLXN) among others .
Click here to see the complete history of Bolzon Bradley J Phd’s form 4 insider trades.
Insider Ownership Summary of Bolzon Bradley J Phd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2020-11-30 | director |
| CRSP | CRISPR Therapeutics AG | 2021-07-19 | director |
| FLXN | Flexion Therapeutics Inc | 2016-06-08 | 10 percent owner |
 | | 2016-05-23 | 10 percent owner |
| | 2014-10-07 | 10 percent owner |
| | 2014-11-18 | 10 percent owner |
| | 2006-05-09 | 10 percent owner |
| | 2006-03-13 | other: Former 10% Holder |
| | 2021-06-23 | director & 10 percent owner |
| | 2014-11-18 | 10 percent owner |
Bolzon Bradley J Phd Latest Holdings Summary
Bolzon Bradley J Phd currently owns a total of 2 stocks. Among these stocks, Bolzon Bradley J Phd owns 6,471,188 shares of Black Diamond Therapeutics Inc (BDTX) as of November 30, 2020, with a value of $38 Million and a weighting of 56.85%. Bolzon Bradley J Phd also owns 498,558 shares of CRISPR Therapeutics AG (CRSP) as of July 19, 2021, with a value of $28 Million and a weighting of 43.15%.
Latest Holdings of Bolzon Bradley J Phd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2020-11-30 | 6,471,188 | 5.80 | 37,532,890 |
| CRSP | CRISPR Therapeutics AG | 2021-07-19 | 498,558 | 57.15 | 28,492,590 |
Holding Weightings of Bolzon Bradley J Phd
Bolzon Bradley J Phd Form 4 Trading Tracker
According to the SEC Form 4 filings, Bolzon Bradley J Phd has made a total of 15 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 1 buys and 14 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 10,393 shares on November 30, 2020, which brought Bolzon Bradley J Phd around $344,528.
According to the SEC Form 4 filings, Bolzon Bradley J Phd has made a total of 19 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 10,000 shares on July 19, 2021, which brought Bolzon Bradley J Phd around $1 Million.
Insider Trading History of Bolzon Bradley J Phd
- 1
Bolzon Bradley J Phd Trading Performance
GuruFocus tracks the stock performance after each of Bolzon Bradley J Phd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bolzon Bradley J Phd is 13.01%. GuruFocus also compares Bolzon Bradley J Phd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bolzon Bradley J Phd within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bolzon Bradley J Phd's insider trading performs compared to the benchmark.
Performance of Bolzon Bradley J Phd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.5 | | | | | |
| Relative Return to S&P 500(%) | 11.04 | | | | | |
Bolzon Bradley J Phd Ownership Network
Bolzon Bradley J Phd Owned Company Details
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Bolzon Bradley J Phd is the director of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , director & 10 percent owner Ali Behbahani , and director & See Remarks David M. Epstein .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Bolzon Bradley J Phd made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,132,213 shares were bought by its insiders, resulting in a net purchase of 5,107,213 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
Bolzon Bradley J Phd Mailing Address
Above is the net worth, insider trading, and ownership report for Bolzon Bradley J Phd. You might contact Bolzon Bradley J Phd via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
